Cardiovascular Financial Statements From 2010 to 2024
CSIIDelisted Stock | USD 20.00 0.00 0.00% |
Check Cardiovascular Systems financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardiovascular Systems' main balance sheet or income statement drivers, such as , as well as many indicators such as . Cardiovascular financial statements analysis is a perfect complement when working with Cardiovascular Systems Valuation or Volatility modules.
Cardiovascular |
Cardiovascular Systems Company Operating Margin Analysis
Cardiovascular Systems' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Cardiovascular Systems Operating Margin | (0.16) % |
Most of Cardiovascular Systems' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cardiovascular Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Cardiovascular Systems has an Operating Margin of -0.1608%. This is 99.54% lower than that of the Health Care Equipment & Supplies sector and 99.59% lower than that of the Health Care industry. The operating margin for all United States stocks is 97.08% lower than that of the firm.
Cardiovascular Systems Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cardiovascular Systems's current stock value. Our valuation model uses many indicators to compare Cardiovascular Systems value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cardiovascular Systems competition to find correlations between indicators driving Cardiovascular Systems's intrinsic value. More Info.Cardiovascular Systems is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cardiovascular Systems' earnings, one of the primary drivers of an investment's value.About Cardiovascular Systems Financial Statements
Investors use fundamental indicators, such as Cardiovascular Systems' revenue or net income, to determine how well the company is positioned to perform in the future. Although Cardiovascular Systems' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota. Cardiovascular Syst operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 725 people.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |